9 August 2021 in International Journal of Implant Dentistry
Background: The aim of this study is to evaluate the implant survival/success rate, gain in alveolar bone height, crestal bone loss, and complications associated with implants placed in the posterior maxilla after osteotome sinus floor elevation without bone substitutes. Methods: The electronic databases, such as MEDLINE, EMBASE, CENTRAL, and SCOPUS were systematically and manually searched for publications in peer-reviewed journals. The included articles were subjected to qualitative and quantitative analyses, and the meta-analysis was carried out for single-arm studies. Methodological quality assessment was made for all the included studies. Results: The included studies were of moderate quality, with the overall implant success and survival rates of 98.3% and 97.9% respectively. The most frequent intra-surgical complication was sinus membrane perforation, accounting for 3.08% of the total implants with reported perforations. The overall crestal bone loss in patients with immediate implants placed with OSFE after a 5-year follow-up was 0.957 mm 95%CI (0.538, 1.377). Conclusion: Within the limitations of this review, it can be concluded that the survival and success rates of implants placed immediately along with OSFE without any bone substitutes are acceptable and show adequate implant stability with less crestal bone loss over 5 years.
24 January 2023 in Pakistan Journal of Medical Sciences
Objective: The current review aimed to assess the efficacy of adjunctive chlorhexidine (CHX) in the non-surgical treatment of peri-implantitis/peri-implant mucositis. Methods: PubMed, Embase, Science Direct, CENTRAL, and Google Scholar databases were searched up to 10th March 2022 for relevant randomized controlled trials or controlled clinical trials. Results: Fourteen studies were included. Meta-analysis revealed significantly lower probing depths in peri-implant mucositis patients using CHX adjuncts as compared to controls (SMD: -1.49 95% CI: -2.56, -0.42 I2=95% p=0.006). However, the same effect was not noted in peri-implantitis (SMD: -1.18 95% CI: -0.04, 2.40 I2=96% p=0.06). CHX was not found to improve bleeding of probing in peri-implant mucositis while sufficient data was unavailable for peri-implantitis. Results on other outcome variables were conflicting. Conclusion: Evidence on the efficacy of adjunctive CHX for peri-implant mucositis is conflicting. Similarly, strong conclusions on the effect of CHX for peri-implantitis cannot be drawn due to limited number of studies. Overall, there seems to be a trend of non-significant impact of CHX on outcomes of peri-implant mucositis as well as peri-implantitis. doi: https://doi.org/10.12669/pjms.39.2.7253 How to cite this: Ye M, Liu W, Cheng S, Yan L. Efficacy of Adjunctive Chlorhexidine in non-surgical treatment of Peri-Implantitis/Peri-Implant Mucositis: An updated systematic review and meta-analysis. Pak J Med Sci. 2023;39(2):595-604. doi: https://doi.org/10.12669/pjms.39.2.7253 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
28 August 2021 in IET Nanobiotechnology
The authors' previous study showed that zirconium oxide nanoparticles (ZrO 2 NPs) induce toxic effects in MC3T3‐E1 cells; however, its toxicological mechanism is still unclear. Liquid chromatography–mass spectrometry/time‐of‐flight mass spectrometry was used to reveal the metabolite profile and toxicological mechanism of MC3T3‐E1 cells in response to ZrO 2 NPs. The results demonstrated that MC3T3‐E1 cells treated with ZrO 2 NPs for 24 and 48 h presented different metabolic characteristics. Following ZrO 2 NP treatment for 24 h, 96 upregulated and 129 downregulated metabolites in the positive ion mode, as well as 91 upregulated and 326 downregulated metabolites in the negative ion mode were identified. Following ZrO 2 NP treatment for 48 h, 33 upregulated and 174 downregulated metabolites were identified in the positive ion mode, whereas 37 upregulated and 302 downregulated metabolites were confirmed in the negative ion mode. Among them, 42 differential metabolites were recognised as potential metabolites contributing to the induced toxic effects of ZrO 2 NPs in MC3T3‐E1 cells. Most of the differential metabolites were lysophosphatidylcholine and lysophosphatidylethanolamide, indicating that exposure to ZrO 2 NPs may have a profound impact on human cellular function by impairing the membrane system. The results also provide new clues for the toxicological mechanism of ZrO 2 NP dental materials.
2 June 2026 in BMC Oral Health
Immediate implant placement (IIP) has emerged as a time-efficient therapeutic approach in dentistry, offering advantages such as reduced treatment duration and improved alveolar bone preservation. However, concerns remain regarding early and late implant failures, and large-scale data on factors associated with IIP failure in Chinese populations are limited. This retrospective observational study aims to identify the factors associated with early and late failure of immediate dental implant. Patients who underwent immediate implantation at the Second Department of Implantology, Xiamen Stomatological Hospital, between January 2013 to December 2022, were retrospectively included. Cumulative survival rates (CSR) at the implant and patient levels were calculated using the life table method and presented with Kaplan-Meier survival curves. Cox regression analysis was performed to evaluate associations between implant failure and demographic, anatomical, surgical, and implant related variables. A total of 1513 implants placed in 781 patients were included. Of these, 50 experienced early failure and 36 experienced late failure. The 10-year CSR at implant level was 93.15% and at patient level 89.46%. Mean survival time was 47.34 ± 34.98 months (range 0-128 months). The mean patient age was 53.02 ± 14.02 years, comprising 46.46% females and 53.54% males. Multivariable analysis showed that male sex (HR = 2.48; 95% CI: 1.31-4.69), maxillary sinus elevation (HR = 2.49; 95% CI: 1.05-5.87), maxillary anterior implant position (HR = 3.15; 95% CI: 1.29-7.69), and maxillary posterior implant position (HR = 2.75; 95% CI: 1.08-6.98) were associated with higher rates of early implant failure, whereas submerged healing was associated with a lower rate of early failure (HR = 0.53; 95% CI: 0.30-0.95). For late implant failure, bone grafting without membrane coverage was associated with increased failure (HR = 3.54; 95% CI: 1.07-11.74), whereas implant diameter of 4.0-4.5 mm was associated with lower late failure compared with ≤ 3.75 mm implants (HR = 0.30; 95% CI: 0.13-0.69). In this large retrospective cohort of Chinese patients, IIP demonstrated favorable long-term survival. Several patient-related and surgical variables were associated with implant failure; however, causal inferences cannot be drawn due to the observational study design.
1 September 2020 in Minerva Medica
Article: Passive medialization of the inferior alveolar nerve to facilitate implant placements in a patient with severe atrophic posterior mandible - Minerva Medica 2020 Sep 17 - Minerva Medica - Journals
5 January 2026 in Pakistan Journal of Medical Sciences
Background and Objective: Lateral wall thickness is an important anatomical entity in sinus lift procedures, but its relationship with crestal bone dimension has received limited attention. This study assessed the association between the thickness of the lateral wall of the maxillary sinus and horizontal crestal bone changes in cases undergoing lateral window sinus lift with simultaneous implant placement and without bone grafts. Methodology: This retrospective study included 35 patients undergoing lateral sinus lift procedures without bone graft and immediate implant placement. Cone-beam computed tomography (CBCT) measurements, including residual bone height (RBH), bone density, and lateral wall thickness, were performed immediate-preoperatively and at six months postoperatively. Change in crestal bone width was compared between patients with lateral wall thickness >1 mm vs. 1 mm while 21 cases had <1 mm. The change in crestal bone width was significantly higher at 2.45±0.97 mm in patients with lateral wall thickness 1 mm. Pearson’s correlation analysis showed statistically significant medium negative relationship between lateral wall thickness and crestal bone width (r=-0.47; p=0.004). A similar relationship was noted with residual ridge height. Conclusion: Lateral wall thickness and RBH may be factors inversely associated with changes in crestal bone width. Incorporating these anatomical determinants into surgical planning may help minimize crestal bone change, and enhance long-term peri-implant stability.